SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending following the announcement of a 10-year AI hosting agreement with Fluidstack, potentially worth billions, which includes Google backstopping a significant portion. The community is excited about this strategic shift from crypto mining to AI infrastructure, anticipating substantial revenue and increased stock value. Some traders believe that the deal is already baked in and that the stock will experience a "sell the news event" as a result.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas is trending amid reports that the U.S. government is considering taking an equity stake in the company, which is fueling speculation of increased government support and reduced dependence on foreign lithium sources. The community is actively discussing the potential for a short squeeze and comparing it to other government-backed ventures, while also weighing analyst downgrades and potential dilution. Some traders are looking at related stocks for similar potential moves.

Aventus Network

Aventus Network ($AVT.X) is gaining traction as traders highlight its strong chart setup and potential breakout, with community members pointing to real-world partnerships and Polkadot integration as possible catalysts. Bullish sentiment is fueled by its low market cap and limited supply, although some express concern about low volume and consistent gains. Recent updates from Aventus on LinkedIn, including news of a new advisor and the integration of their technology with Heathrow Airport and Vodafone, appear to be contributing to the increased interest.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending due to positive Phase 2a trial results for its pancreatic cancer treatment, showing high overall survival rates. Despite the encouraging data, the stock's momentum is tempered by the announcement of a $175 million public offering and a $25 million private placement to Sanofi, leading to community debate about dilution and fair valuation. The community is actively discussing the potential for long-term growth versus short-term price suppression from the offering, as well as comparisons to other companies in the sector.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around recent developments, including a listing on Bifinance and the promise of more burns and contests. Talk centers on its undervaluation compared to other meme coins, along with airdrops and staking on the horizon. The community emphasizes their dedication and consistent efforts towards the project's growth.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to positive trial data showing significant slowing of Huntington's disease progression with its gene therapy, potentially paving the way for FDA approval. The community is buzzing about the therapy's efficacy and potential market impact, while also weighing concerns of dilution following the announcement of a public offering and insider selling. Bullish investors are focused on long-term potential in a growing biotech sector, while bears are skeptical of the recent surge and near-term dilution.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss potential partnerships and the upcoming earnings report. The community is focused on a possible short squeeze, with some expressing strong bullish sentiment. There is also speculation about unusual ticker behavior on some platforms and what it could mean for the stock's future.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending amid excitement around quantum computing, with community members discussing potential catalysts like government contracts and advancements in qubit technology. Some are pointing to a recent Air Force contract and comparing it to other high-flying stocks, while others express concern about the company's valuation and potential for a pullback. Overall, the conversation is focused on whether the stock's momentum can continue, given the speculative nature of the quantum computing sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as community members discuss its valuation and potential for future growth within the quantum computing sector. Conversations include commentary around a recent photon conversion breakthrough, and whether the company can deliver on long-term promises. Short sellers and bullish investors are actively debating the stock's near-term direction and long-term potential.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending amid speculation of a potential takeover, with community members citing a blog report about a strategic buyer possibly seeking a bridge loan for the acquisition. The community is actively discussing potential acquirers and deal structures, while also considering the company's fundamentals and upcoming catalysts. Some traders believe that this could present an opportunity for the company's value to be unlocked.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Carnival Corp. (CCL) rose nearly 0.4% pre-market on Tuesday after the company’s <a href="https://stocktwits.com/news-articles/markets/equity/ccl-stock-dips-after-earnings-retail-stays-bullish/c76dXtiR3B">Q3 earnings report</a> sparked mixed reactions.On Monday, the stock initially dropped more than 6% but pared some losses to close slightly in the red after a softer-than-expected forecast for current-quarter net yields and profits overshadowed a profit beat and record quarterly revenue, dampening market sentiment.Despite the cautious outlook, Carnival raised its full-year profit guidance for the third time this year and lifted its net yield forecast to 10.4%, up from 10.25%.Barclays raised its price target on Carnival to $26 from $25, representing about 40% upside from current levels, while maintaining an ‘Overweight’ rating.The brokerage noted that while the Q3 results didn’t meet all expectations, strong demand and positive commentary keep Carnival’s 2025 outlook intact.Morgan Stanley also adjusted its price target, raising it to $16.50 from $15, but stuck with an ‘Underweight’ rating.The brokerage increased its EPS forecasts for FY24, FY25, and FY26 but expressed concerns about Carnival’s asset-heavy model and high financial leverage, which could make it more vulnerable to a potential slowdown compared to other travel names.Carnival has made progress on reducing its pandemic-era debt, which ballooned from $11.5 billion in 2019 to $34.5 billion in 2022. Since then, the company has reduced its debt by $5 billion.But on Monday, CEO Josh Weinstein expressed confidence in the company’s future, pointing to “enhanced commercial execution” and strong booking momentum, positioning Carnival for a solid 2025 and beyond.<figure class="image"><a href="https://stocktwits.com/symbol/CCL"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CCL_sentiment_and_message_volume_Oct_1_f412f043e2.png" alt="CCL sentiment and message volume Oct 1.png" width="1314" height="320"></a><figcaption>CCL sentiment and message volume Oct 1 pre-market</figcaption></figure>On Stocktwits, retail sentiment surged to ‘extremely bullish’ (95/100) levels, nearing the highest point this year, with a 36% spike in message volume.One user commented on the bullish outlook, noting the stock’s recovery and positive future trend.<stembedurl>https://stocktwits.com/Davruns/message/587589067</stembedurl>Another user looked ahead to a higher target price.<stembedurl>https://stocktwits.com/2023andbeyond/message/587617901</stembedurl>Shares of Carnival are up over 6% year-to-date, as of Monday’s close, compared to Norwegian Cruise Line’s (NCLH) 12% gain and Royal Caribbean’s (RCL) 47% surge. &nbsp;

Barclays raised its price target on Carnival to $26 from $25, representing about 40% upside from current levels.

Carnival Gets Price-Target Hikes After Q3 Earnings: Stock Rises, Retail Sentiment Near Year’s High

Barclays noted that while the Q3 results didn’t meet all expectations, strong demand and positive commentary keep Carnival’s 2025 outlook intact.

Equity

Beverage and coffeemaker conglomerate Keurig Dr Pepper announced its second-quarter results on Thursday with most metrics aligning with analyst estimates. Diluted earnings per share (EPS) came in at $0.45 while revenue stood at $3.92 billion, both in line with analyst estimates. Shares of the company traded over 2% higher on the news, with Stocktwits sentiment reaching a bullish zone (67/100) supported by extremely high message volume.<figure class="image"><img style="aspect-ratio:1582/448;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_25_at_1_32_22_PM_79a80ac8a7.png" alt="Retail sentiment trends in bullish territory for Keurig Dr Pepper" width="1582" height="448"><figcaption>Retail sentiment trends in bullish territory for Keurig Dr Pepper</figcaption></figure>During the second quarter, adjusted operating income rose 11% to $970 million led by higher net price realization and net productivity. Operating margin stood at 24.70% for the period. Meanwhile, adjusted net income rose 3.20% year-over-year (YoY) to $618 million.According to a CNBC report that cited Beverage Digest, Dr. Pepper recently surpassed Pepsi as the second-most consumed soda in the country.From a segment perspective, the US refreshment beverages net sales grew 3.30% to $2.40 billion driven by net price realization of 2.90%. Adjusted operating income rose 11.90% to $723 million with a healthy operating margin of 30%. However, the US Coffee segment witnessed a 2.10% decline in its net sales to $1 billion. International net sales rose 15.50% to $0.6 billion.CEO Tim Cofer stated that strong execution drove the company’s performance in the second quarter. “Now halfway through 2024, we are on track to achieve our unchanged full year outlook, while also seeding initiatives to fuel consistent growth over multiple years,” he said.The company reaffirmed its fiscal 2024 guidance for constant currency net sales growth in a mid-single-digit range, also projecting adjusted diluted EPS growth in a high-single-digit range.The year hasn’t been great for Keurig Dr Pepper stock with the shares basically flat YTD. Still, retail investors are betting on a rebound, citing pricing power and volume growth its competitors have been unable to achieve.One Stocktwits user named ‘Morechumanthanhuman’ expressed bullishness on the stock and stated that shares of the beverage-maker could move back to 40 on the back of these results.<figure class="image"><a href="https://stocktwits.com/Morechumanthanhuman/message/580656707"><img style="aspect-ratio:1534/454;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_25_at_1_33_31_PM_c38eeee921.png" alt="Stocktwits user Morechumanthanhuman's post on Keurig Dr Pepper" width="1534" height="454"></a><figcaption>Stocktwits user Morechumanthanhuman's post on Keurig Dr Pepper</figcaption></figure> Photo Courtesy: Brandon Richardson on Pexels

Keurig Dr Pepper Quenches Retail Investors’ Thirst For Earnings

The beverage-maker’s second quarter results were in line with analyst estimates, but retail investors are optimistic about management’s execution in a challenging retail consumer environment.

Neuberger Berman ETF Trust - Neuberger Berman Next Generation Connected Consumer ETF

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

NBCC
Neuberger Berman ETF Trust - Neuberger Berman Next Generation Connected Consumer ETF

Feed

News

Sentiment

Fundamentals

Info

Latest NBCC News

NBCC Neuberger Berman ETF Trust - Neuberger Berman Next Generation Connected Consumer ETF